Published 7 days ago • loading... • Updated 7 days ago

AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE

On May 21, 2025, at 9:00 a.m. ET, Amgen will deliver a presentation from Thousand Oaks, California, at an upcoming major healthcare investor event hosted by RBC Capital Markets.
The presentation follows an announcement made on May 16, 2025, by Amgen, which is recognized as a leading biotechnology company included in major indexes like the Dow Jones Industrial Average.
Kave Niksefat, who leads Amgen’s Global Marketing and Access efforts as an executive vice president, will present during a live webcast attended by investors, media representatives, and the general public.
The webcast will stream simultaneously on the internet and remain archived for replay for at least 90 days, while Amgen continues to receive accolades like "World's Most Innovative Companies" and "America's Best Large Employers" in 2024.
This event highlights Amgen’s ongoing efforts to engage stakeholders about its innovative medicines pipeline and maintain visibility as a leading player in the healthcare sector.

Insights by Ground AI

Does this summary seem wrong?

26 Articles

All

Left

Center

Right

Helena Independent Record

+24 Reposted by 24 other sources

Center

AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif., May 16, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2025 RBC Capital Markets Global Healthcare Conference at 9:00 a.m. ET on Wednesday, May 21, 2025. Kave Niksefat, senior vice president of Global Marketing and Access…

7 days ago·Helena, United States

Read Full Article

themarketsdaily.com

Snowden Capital Advisors LLC Trims Stock Position in Amgen Inc. (NASDAQ:AMGN)

Snowden Capital Advisors LLC trimmed its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 20.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 30,585 shares of the medical research company’s stock after selling 8,086 shares during the period. Snowden Capital Advisors LLC’s holdings in Amgen were worth $7,972,000 at the end […]

7 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year